MAP

WIPO WIPO 2007

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke MAP wurde als Wortmarke am 02.11.2007 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 20. März 2018

Markenform Wortmarke
Aktenzeichen 972486
Länder Europäische Gemeinschaft
Basismarke US Nr. , 26. November 2024
Anmeldedatum 02. November 2007
Ablaufdatum 02. November 2027

Markeninhaber

2525 Dupont Drive
Irvine, CA 92612
US

Waren und Dienstleistungen

05 Pharmaceutical products for use in the treatment of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; pre-filled drug cartridges, sold with inhalers, which deliver medication in liquid form via the pulmonary route, either directly to the lungs or for absorption and delivery in systemic circulation for use in the treatment of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; pre-filled drug cartridges, sold with inhalers, which deliver medication in liquid form via the pulmonary route, either directly to the lungs or for absorption and delivery in systemic circulation for use in the delivery of cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations.
42 Pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment of respiratory diseases and disorders and central nervous system diseases and disorders; research and development of drug delivery devices, both with and without pre-filled drug cartridges, for delivery of medication via the pulmonary route; medical and scientific research, namely conducting clinical trials.
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
02. November 2017 2017/44 Gaz Verlängerung
06. April 2012 2012/23 Gaz US RAW: Partial Ceasing Effect
03. November 2009 2009/45 Gaz EM Ablehnung
03. Dezember 2008 2009/3 Gaz US RAW: Division or Merger of Basic Registration
02. November 2007 2008/34 Gaz US Eintragung

ID: 14972486